HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Estey Selected Research

Chromatin

2/2016A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Estey Research Topics

Disease

18Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 09/2000
11Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2016 - 02/2000
8Leukemia
02/2016 - 02/2000
8Neoplasms (Cancer)
03/2007 - 09/2000
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2007 - 09/2000
4Acute Promyelocytic Leukemia
08/2006 - 01/2001
2Hematologic Neoplasms (Hematological Malignancy)
03/2007 - 01/2001
2Mycoses (Diseases, Fungus)
10/2001 - 02/2001
2Mucositis
07/2001 - 07/2001
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
09/2000 - 02/2000
1Primary Myelofibrosis (Myelosclerosis)
02/2016
1Cerebral Hemorrhage
08/2006
1Myeloid Sarcoma (Chloroma)
06/2003
1Refractory Anemia with Excess of Blasts (RAEM)
11/2002
1Neutropenia
09/2002
1Thrombocytopenia (Thrombopenia)
09/2002
1Hyperuricemia
10/2001
1Hyperbilirubinemia
07/2001
1Infections
07/2001
1Pneumonia (Pneumonitis)
02/2001
1Retinoblastoma (Glioblastoma, Retinal)
11/2000
1Myeloid Leukemia (Leukemia, Myelocytic)
11/2000
1Necrosis
09/2000

Drug/Important Bio-Agent (IBA)

3Gemtuzumab (Mylotarg)FDA Link
02/2016 - 07/2001
2CalicheamicinsIBA
02/2016 - 09/2002
2Proteins (Proteins, Gene)FDA Link
06/2007 - 07/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2001 - 09/2000
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2001 - 09/2000
2Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2001 - 01/2001
2Cytarabine (Cytosar-U)FDA LinkGeneric
07/2001 - 02/2000
2Topoisomerase I InhibitorsIBA
01/2001 - 02/2000
1EpitopesIBA
02/2016
1DecitabineFDA Link
02/2016
1ChromatinIBA
02/2016
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
06/2007
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2007
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
08/2006
1fludarabineIBA
05/2003
1DNA (Deoxyribonucleic Acid)IBA
01/2003
1Annexin A5IBA
11/2002
1Anti-Bacterial Agents (Antibiotics)IBA
09/2002
1Sialic Acid Binding Ig-like Lectin 3IBA
09/2002
1CreatinineIBA
10/2001
1Micafungin (FK463)FDA Link
10/2001
1Itraconazole (Sporanox)FDA LinkGeneric
10/2001
1Mitogen-Activated Protein KinasesIBA
09/2001
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
09/2001
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2001
12- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA
09/2001
1EnzymesIBA
08/2001
1angiogeninIBA
08/2001
1Transaminases (Aminotransferases)IBA
07/2001
1Daunorubicin (Cerubidine)FDA LinkGeneric
07/2001
1acivicin (AT 125)IBA
07/2001
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2001
1liposomal amphotericin BFDA Link
02/2001
1acylfulveneIBA
01/2001
1promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
01/2001
1irofulvenIBA
01/2001
1Retinoic Acid Receptor alphaIBA
01/2001
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
11/2000
1Oncogene Proteins (Oncogene Protein)IBA
11/2000
1Proto-Oncogene Proteins c-mdm2IBA
11/2000
1Cyclin-Dependent Kinase Inhibitor p16IBA
11/2000
1Retinoblastoma ProteinIBA
11/2000
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
09/2000
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2000
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2000
1Transforming Growth Factor alpha (TGF-alpha)IBA
09/2000
1Topotecan (Hycamtin)FDA LinkGeneric
02/2000
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2000

Therapy/Procedure

6Therapeutics
01/2017 - 06/2001
6Drug Therapy (Chemotherapy)
02/2016 - 07/2001
2Transplantation
09/2002 - 02/2001
1Remission Induction
02/2014
1Radiotherapy
06/2003
1Blood Component Removal (Apheresis)
06/2001